CEPTYR, INC.

CEPTYR

Pharmaceutical preparations for use in the treatment of cancer, diabetes, autoimmune disease, obesity, infectious diseases and inflammation;Assay reagents, cellular enzymes, recombinant nucleic acids, antisense nucleic acids, recombinant proteins, gene vectors, host cells, ribozymes, protein tyrosine phosphatases, mutated protein tyrosine phosphatases, nucleic acids encoding protein tyrosine phosphatases, recombinant nucleic acids for use in the manufacture of recombinant proteins, ribozymes and antisense molecules, antisense nucleic acid for use in the manufacture of regulators of gene expression, and cellular enzymes for use in the manufacture of biologicals, all sold directly to scientists and all for scientific or medical research u se; and biochemicals, namely, monoclonal antibodies sold directly to scientists for in vitro or scientific of medical research use;

CEPTYR

SCIENTIFIC RESEARCH AND DEVELOPMENT SERVICES FOR OTHERS IN THE FIELDS OF THERAPEUTICS, PHARMACEUTICALS, MOLECULAR GENETICS, BIOCHEMISTRY, CELL BIOLOGY, AND BIOLOGICAL SIGNAL TRANSDUCTION PATHWAYS; SCIENTIFIC RESEARCH, NAMELY, CONDUCTING STRUCTURE-FUNCTION CHARACTERIZATION OF MOLECULES FOR OTHERS AND CLONING GENES FOR OTHERS; SCIENTIFIC RESEARCH TO IDENTIFY COMPOUNDS LIKELY TO HAVE DRUG ACTIVITY; AND MEDICAL RESEARCH, NAMELY, PERFORMING DIAGNOSTIC ASSAYS FOR OTHERS;

CEPTYR

The mark consists of the word CEPTYR centered directly below an arcing arrow positioned between two circles.;Pharmaceutical preparations for use in the treatment of cancer, diabetes, autoimmune disease, obesity, infectious diseases and inflammation;Color is not claimed as a feature of the mark.;The stippling is for shading purposes only.;